The US federal government will not move psilocybin (the active compound in 'magic mushrooms') or MDMA (often called 'ecstasy') off the most restricted drug list in 2026. Congress is currently focused on funding for trauma and school safety — not on changing how these drugs are classified. This means no federally legal access to these substances outside of approved research studies.
Today's bills are trauma grants and school safety, not scheduling. Scheduling changes require completed reviews we don't have.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →